These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23469311)

  • 61. Human African trypanosomiasis with 7-year incubation period: clinical, laboratory and neuroimaging findings.
    Wengert O; Kopp M; Siebert E; Stenzel W; Hegasy G; Suttorp N; Stich A; Zoller T
    Parasitol Int; 2014 Jun; 63(3):557-60. PubMed ID: 24613272
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
    Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
    Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.
    Lejon V; Legros D; Savignoni A; Etchegorry MG; Mbulamberi D; Büscher P
    J Neuroimmunol; 2003 Nov; 144(1-2):132-8. PubMed ID: 14597107
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Survival of Trypanosoma brucei brucei in cerebrospinal fluid.
    Pentreath VW; Owolabi AO; Doua F
    Ann Trop Med Parasitol; 1992 Feb; 86(1):29-34. PubMed ID: 1616393
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diagnosis of Trypanosoma brucei gambiense sleeping sickness using an antigen detection enzyme-linked immunosorbent assay.
    Nantulya VM; Doua F; Molisho S
    Trans R Soc Trop Med Hyg; 1992; 86(1):42-5. PubMed ID: 1566302
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test.
    Lejon V; Legros D; Richer M; Ruiz JA; Jamonneau V; Truc P; Doua F; Djé N; N'Siesi FX; Bisser S; Magnus E; Wouters I; Konings J; Vervoort T; Sultan F; Büscher P
    Trop Med Int Health; 2002 Aug; 7(8):685-92. PubMed ID: 12167095
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial.
    Van Nieuwenhove S; Schechter PJ; Declercq J; Boné G; Burke J; Sjoerdsma A
    Trans R Soc Trop Med Hyg; 1985; 79(5):692-8. PubMed ID: 3938090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial.
    Burri C; Nkunku S; Merolle A; Smith T; Blum J; Brun R
    Lancet; 2000 Apr; 355(9213):1419-25. PubMed ID: 10791526
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness.
    Pepin J; Milord F; Guern C; Schechter PJ
    Lancet; 1987 Dec; 2(8573):1431-3. PubMed ID: 2891995
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.
    Khonde N; Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.
    Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U
    Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis.
    Mumba Ngoyi D; Lejon V; N'Siesi FX; Boelaert M; Büscher P
    Trop Med Int Health; 2009 Apr; 14(4):438-44. PubMed ID: 19228348
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
    Lüscher A; de Koning HP; Mäser P
    Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant.
    Mpandzou G; Cespuglio R; Ngampo S; Bandzouzi B; Bouteille B; Vincendeau P; Buguet A
    J Neurol Sci; 2011 Jun; 305(1-2):112-5. PubMed ID: 21470639
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients.
    Lejon V; Büscher P; Magnus E; Moons A; Wouters I; Van Meirvenne N
    Acta Trop; 1998 May; 69(2):151-64. PubMed ID: 9588235
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G; Schmid C; Loutan L; Chappuis F
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Contribution to the study of cerebrospinal fluid in the sleeping sickness due to Trypanosoma gambiense].
    NEUJEAN G
    Rev Med Liege; 1951 Nov; 6(21):720-9. PubMed ID: 14883610
    [No Abstract]   [Full Text] [Related]  

  • 78. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda.
    Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC
    Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda.
    Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.